Analysis of the Efficacy and Pharmacological Mechanisms of Action of Zhenren Yangzang Decoction on Ulcerative Colitis Using Meta-Analysis and Network Pharmacology

Objective. We analyzed the efficacy and pharmacological mechanisms of action of Zhen Ren Yang Zang decoction (ZRYZD) on ulcerative colitis (UC) using meta-analysis and network pharmacology. Methods. The major databases were searched for randomized controlled trials of ZRYZD for the treatment of UC. Meta-analysis of the efficacy of ZRYZD on UC was conducted using RevMan software. Active compounds and target genes were acquired using the Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform. UC-related genes were searched using the GeneCards database. Gene Ontology (GO) functional enrichment and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses were performed using RGUI. A compound-target network was constructed using Cytoscape software, and a protein-protein interaction network was constructed using the STRING database. Molecular docking simulations of the macromolecular protein targets and their corresponding ligand compounds were performed using the AutoDock tool and AutoDock Vina software. Results. Meta-analysis revealed that the total effective rate and recovery rate of clinical efficacy were significantly higher in the experimental group than those of the control group. The screening identified 169 active compounds and 277 active target genes for ZRYZD. The 277 active target genes were compared with the 4,798 UC-related genes. This identified 187 active target genes of ZRYZD for UC that correlated with 138 active compounds. GO functional enrichment and KEGG pathway enrichment analyses were performed, and compound-target and protein-protein interaction networks were constructed. The key compounds and key target proteins were then selected. Finally, target protein binding with the corresponding compound was analyzed using molecular docking. Conclusion. Our findings demonstrate the effectiveness and safety of ZRYZD for the treatment of UC and provide insight into the underlying pharmacological mechanisms of action. Furthermore, key compounds were identified, laying the foundation for future studies on ZRYZD for the treatment of UC.

An LGAD-Based Full Active Target for the PIONEER Experiment

PIONEER is a next-generation experiment to measure the charged pion branching ratios to electrons vs. muons Re/μ=Γπ+→e+ν(γ)Γπ+→μ+ν(γ) and pion beta decay (Pib) π+→π0eν. The pion to muon decay (π→μ→e) has four orders of magnitude higher probability than the pion to electron decay (π→eν). To achieve the necessary branching-ratio precision it is crucial to suppress the π→μ→e energy spectrum that overlaps with the low energy tail of π→eν. A high granularity active target (ATAR) is being designed to suppress the muon decay background sufficiently so that this tail can be directly measured. In addition, ATAR will provide detailed 4D tracking information to separate the energy deposits of the pion decay products in both position and time. This will suppress other significant systematic uncertainties (pulse pile-up, decay in flight of slow pions) to <0.01%, allowing the overall uncertainty in to be reduced to O (0.01%). The chosen technology for the ATAR is Low Gain Avalanche Detector (LGAD). These are thin silicon detectors (down to 50 μm in thickness or less) with moderate internal signal amplification and great time resolution. To achieve a 100% active region several emerging technologies are being evaluated, such as AC-LGADs and TI-LGADs. A dynamic range from MiP (positron) to several MeV (pion/muon) of deposited charge is expected, the detection and separation of close-by hits in such a wide dynamic range will be a main challenge. Furthermore, the compactness and the requirement of low inactive material of the ATAR present challenges for the readout system, forcing the amplifier chip and digitizer to be positioned away from the active region.

Pixel chamber: a solid-state active-target for 3D imaging of charm and beauty

The aim of the pixel chamber project is to develop the first “solid-state bubble chamber” for high precision measurement of charm and beauty. In this paper we will describe the idea for the first silicon active target conceived as an ultra-high granular stack of hundreds of very thin monolithic active pixel sensors (MAPS), which provides continuous, high-resolution 3D tracking of all of the particles produced in proton-silicon interactions occurring inside the detector volume, including open charm and beauty. We will also discuss the high-precision tracking and vertexing performances, showing that the vertex resolution can be up to one order of magnitude better than state-of-the-art detectors like the LHCb one.

MuSun - Muon Capture on the Deuteron

The MuSun experiment is a precision measurement of the rate for nuclear muon capture on the deuteron, designed to resolve a long-standing disagreement between experiment and theory, and to determine an important low-energy constant relevant for a variety of weak and strong dynamics. The experiment is based on a novel active target method employing a pure deuterium cryogenic time-projection chamber. The data taking was completed in two main campaigns and the analysis is well advanced. The unique challenges and corresponding strategy of the experiment as well as the status of the analysis are presented.